MicroPort NeuroTech Ltd. engages in the business of research and development, manufacturing, and selling neuro-interventional medical devices. It is also involved in developing comprehensive stroke interventional treatment product line covering the three major areas of neurovascular disease namely hemorrhagic stroke, cerebral atherosclerotic stenosis, and acute ischemic stroke. The company was founded in 2012 and is headquartered in Shanghai, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company